Phase I study of a new antianxiety drug, buspirone. 1989

M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
Department of Psychiatry, Kitasato University, School of Medicine, Sagamihara, Japan.

1. A phase I study of buspirone was conducted in 7 healthy male volunteers. 2. Diazepam was selected as the control drug and administered in equipotent doses to buspirone. Dosage was initiated at 2.5mg and doubled until a maximum dosage of 20mg was attained. Subsequently, 10mg was administered once a day for three consecutive days. 3. Clinico-pharmacologically both drugs produced sleepiness/drowsiness, but dizziness, light-headed feeling and feeling of drunkenness were marked only in the diazepam group. 4. No drug-related abnormalities were observed in clinical laboratory test values, endocrinological tests and ECG. 5. On the Uchida-Kraepelin test, no change with the control values was observed under buspirone but subjects administered diazepam exhibited marked deterioration during the latter half of the test. Moreover, in the tapping test, significant impairment was observed in the diazepam group whereas buspirone had no effect. 6. On the EEG some fast waves were observed with diazepam whereas buspirone exhibited slow waves.

UI MeSH Term Description Entries
D008297 Male Males
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002065 Buspirone An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM. Anxut,Apo-Buspirone,Bespar,Busp,Buspar,Buspirone Hydrochloride,Gen-Buspirone,Lin-Buspirone,MJ-9022-1,N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide,Neurosine,Novo-Buspirone,Nu-Buspirone,PMS-Buspirone,Ratio-Buspirone,Apo Buspirone,Gen Buspirone,Hydrochloride, Buspirone,Lin Buspirone,MJ 9022 1,MJ90221,Novo Buspirone,Nu Buspirone,PMS Buspirone,Ratio Buspirone
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005425 Flicker Fusion The point or frequency at which all flicker of an intermittent light stimulus disappears. Flicker Fusions,Fusion, Flicker,Fusions, Flicker
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
January 1989, Drug metabolism and disposition: the biological fate of chemicals,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
January 1989, Drug metabolism and disposition: the biological fate of chemicals,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
April 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
June 1987, North Carolina medical journal,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
April 1963, JAMA,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
November 1989, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
April 1979, Psychopharmacology bulletin,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
August 1990, Xenobiotica; the fate of foreign compounds in biological systems,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
April 1996, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
M Murasaki, and S Miura, and J Ishigooka, and Y Ishii, and A Takahashi, and Y Fukuyama
April 1990, Revista clinica espanola,
Copied contents to your clipboard!